Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.

Autor: Dungan, Lara, Dunne, Jean, Savio, Michael, Kalaszi, Marianna, McElheron, Matt, Lynagh, Yvonne, O'Driscoll, Kate, Roche, Carmel, Qureshi, Ammara, Crowley, Brendan, Conlon, Niall, Kearney, Hugh
Zdroj: Neurology® Neuroimmunology & Neuroinflammation; May2024, Vol. 11 Issue 3, p1-11, 11p
Databáze: Complementary Index